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 “ Let food be thy medicine and 
let medicine be thy food. ” 
     — Hippocrates (ca. 460 – 377  BC ) 
 Dietary interventions have been a corner-
stone of medicine since its early days. 
In patients with chronic kidney disease 
(CKD), dietary advice focuses mainly on 
restricting intake of dietary salt, phos-
phorus, potassium, and proteins. Th e role 
of dietary fi ber intake in patients with 
CKD is less well defi ned, and evidence-
based nutrition practice guidelines for 
CKD patients, such as the Kidney Disease 
Outcomes Quality Initiative (KDOQI) 
guide lines on nutrition in chronic renal 
failure, do not even discuss dietary fi ber 
intake. Th e fi ndings of Krishnamurthy 
 et al. 1 (this issue) suggest that this neglect 
is unjustifi ed. 
 The authors used the Third National 
Health and Nutrition Examination Survey 
(NHANES III) database to examine 
whether the associations between dietary 
fi ber intake, elevated C-reactive protein, 
and all-cause mortality are modifi ed by 
CKD. Total dietary fi ber intake averaged 
17  g / d, which is far below the 20 – 30  g / d 
recommended by current guidelines for 
the general population. Not unexpectedly, 
dietary fi ber intake was even less in patients 
with CKD (15  g / d). Fruits and vegetables, 
oft en restricted in advanced CKD to pre-
vent or correct hyperkalemia, are an 
important source of dietary fi ber. Litera-
ture data confi rm that dietary fi ber intake 
is particularly low in advanced CKD. 2 
 In the overall study population, it was 
found that high fi ber intake was associated 
with lower infl ammation. Although this 
association was found both in non-CKD 
and in CKD patients, it was signifi cantly 
stronger in CKD patients. Only in the sub-
group of patients with CKD, dietary fi ber 
intake was also associated with mortality 
risk. Each 10-g / d increase in intake was 
associated with a hazard ratio of 0.83 (total 
fi ber), 0.77 (insoluble fi ber), and 0.67 (sol-
uble fi ber) for overall mortality. Th is large 
population-based observational study thus 
suggests that the presence of CKD is a 
potent modifi er of the benefi cial eff ects of 
dietary fi ber intake. 
 Evidently, association is not proof of 
causation. Examination of the dietary 
impact on health outcomes in observa-
tional studies is subject to confounding 
bias, no matter how rigorous the statistical 
adjustments are. Intake of dietary fi ber 
may indeed be a marker for some other 
risk-reducing behavior or clinical charac-
teristic. Recent examples where the results 
of observational studies were refuted by 
randomized controlled trials serve as a 
cautionary tale against using observational 
data as fi nal proof of a bene fi cial eff ect. A 
set of criteria for making the leap from 
association to causation was systematically 
presented in a 1965 article by Sir Austin 
Bradford Hill,  ‘ The environment and 
disease: association or causation? ’ 3 As 
 Table 1 shows, the application of Hill ’ s cri-
teria to the available evidence on dietary 
fi ber intake shows that most criteria appear 
to be satisfi ed. Th is lends support to the 
thesis that the observed associations 
between dietary fi ber intake and improved 
outcomes reflect causality. How, then, 
should we understand the mechanisms 
behind the beneficial effects of dietary 
fi ber intake, and how does kidney function 
modify these eff ects? 
 Available literature indicates that 
dietary fi ber reduces the risk of death 
from cardiovascular, infectious, and res-
piratory diseases. Associations of fi ber 
intake with various cancers, conversely, 
are less unambiguous. 4 Unfortunately, 
the study by Krishnamurthy  et al. 1 was 
underpowered to distinguish among 
causes of death. 
 Humans are increasingly thought of as a 
composite of microbial and human cells 
with close genetic and metabolic inter-
action (so-called  ‘ supra-organisms ’ ). 5 Th e 
benefi cial eff ects of dietary fi ber may be the 
results of modification of the colonic 
microbial metabolism. Dietary fi ber shift s 
the colonic microbial activity from a pro-
teolytic toward a saccharolytic fermenta-
tion pattern. This results in decreased 
generation of indoles and phenols (includ-
ing  p -cresol) and increased production of 
short-chain fatty acids. 
 First, increased production of short-
chain fatty acids inhibits hepatic choles-
terol synthesis by limiting the action of 
3-hydroxy-3-metylglutaryl – coenzyme 
A reductase. In addition, short-chain 
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fatty acids improve insulin sensitivity. 
More over, dietary fi ber aff ects fi brinolysis 
and coagulation, which may be parti-
cularly important in the setting of estab-
lished atherosclerotic plaques. Fiber also 
increases the production of cholesterol-
binding bile acids, which promotes the 
excretion of lipids. 
 Second, mounting experimental and 
clinical evidence indicates that indoxyl 
sulfate and  p -cresyl sulfate (sulfate conju-
gates of indole and  p -cresol) contribute to 
cardiovascular and bone disease and 
accelerate the progression of renal disease 
in CKD patients. 6,7 Serum concentrations 
of both indoxyl sulfate and  p -cresyl sulfate 
rise parallel to the loss of kidney function. 
Interestingly, serum concentrations vary 
widely in subjects with similar estimated 
glomerular filtration rates, reflecting, 
among others, diff erences in dietary fi ber 
intake (P.E., unpublished data). 
 Notably, adjustment for C-reactive 
protein levels eliminated the association 
between dietary fi ber and mortality in 
the study by Krishnamurthy  et al. 1 Th is 
suggests that inflammation is in the 
causal pathway between dietary fi ber and 
mortality. Th is observation is consistent 
with a growing body of literature sug-
gesting that the infl ammatory process is 
a major contributor to the development 
of atherosclerosis and, hence, cardio-
vascular disease. 
 As is mentioned above, dietary fi ber 
suppresses the colonic generation of 
indoxyl sulfate and  p -cresyl sulfate, which 
may trigger vascular infl ammation and 
subsequently induce a systemic infl amma-
tory response. In addition, food items rich 
in dietary fi ber may contain components 
with antioxidant and anti-infl ammatory 
properties. Finally, base-inducing pro-
teins, abundant in fruit and vegetables, 8 
may counter acidosis and thus attenuate 
infl ammation. 9 
 Opposite to dietary fi ber, dietary pro-
tein promotes proteolytic fermentation, 
increases the nutritional acid load, and is 
associated with poor outcomes. 7 
 Th ese new insights potentially explain 
why a  ‘ Mediterranean ’ diet protects 
against cardiovascular disease whereas a 
 ‘ Western ’ diet (characterized by a high 
intake of processed meat, red meat, 
butter, high-fat dairy products, and 
refi ned grains) confers an increased risk 10 
( Figure 1 ). Th e question of whether the 
observed association between dietary 
fi ber and cardiovascular morbidity and 
mortality truly refl ects causality can be 
answered only by randomized controlled 
trials. In designing such a study, it is 
important to know whether the source 
(fruit, vegetables, grains, and so on) and /
 or type (soluble versus insoluble) of die-
tary fi bers is relevant. Available data are 
not unequivocal, and biological mecha-
nisms for observed diff erences have not 
been completely elucidated. 
 Prebiotics are an attractive alternative 
to dietary fi ber.  ‘ Prebiotic ’ refers to  ‘ a 
non-digestible food ingredient that ben-
efi cially aff ects the host by selectively 
stimulating the growth and / or activity 
of one or a limi ted number of bacteria 
in the colon, and thus improves host 
health. ’ 11 Whereas numerous com-
pounds are known to escape digestion 
in the small intestine, only a limited 
number of molecules result in selective 
stimulation of microbiota. Today, only 
bifi dogenic, non-digestible oligosaccha-
rides — particularly inulin, its hydrolysis 
product oligofructose, arabinoxylan-oli-
gosaccharides, and (trans) galacto-oli-
gosaccharides — fulfi ll all the criteria to 
be classifi ed as prebiotics. Preliminary 
evidence indicates that prebiotics sup-
press proteolytic fermentation in both 
CKD 12 and non-CKD populations. 13 An 
additional advantage for patients with 
advanced CKD is that they are free of 
potassium. Moreover, arabinoxylan-
oligo saccharides have been shown to 
have antioxidant properties. 14 
 Table 1  |  Dietary fi ber and mortality: Hill ’ s criteria of causation 
 Criterion  Defi nition / comments  Applied to dietary fi ber 
 1. Temporal 
relationship 
 Exposure always precedes the 
outcome 
 High dietary fi ber intake is 
followed by improved survival 
 2. Strength 
of association 
 The stronger the association, the 
more likely it is that the relation 
is causal 
 Most studies indicate a strong posi-
tive association with survival. Still, 
the association may be confounded, 
even after multiple adjustments 
 3. Dose response  Increasing amount of exposure 
increases the risk proportionally 
 The higher the intake of dietary 
fi ber, the better the outcome 
 4. Consistency of 
results 
 The association is consistent when 
results are replicated in studies in 
diff erent settings using diff erent 
methods 
 Consistent results in diff erent 
cohorts (from diff erent countries) 
 5. Biological 
plausibility 
 The association agrees with 
currently accepted understanding 
of pathological processes. 
However, studies that disagree 
with established understanding 
of biological processes may force 
a reevaluation of accepted beliefs 
 The eff ects of dietary fi ber on 
various cardiovascular and meta-
bolic processes provide a plausi-
ble explanation for the benefi cial 
eff ect of a high-dietary-fi ber diet 
 6. Experimentation  The condition can be altered 
(prevented or ameliorated) 
by an appropriate experimental 
regimen 
 Randomized controlled trials examin-
ing the benefi t of a high-dietary-fi ber 
diet have been  limited and yielded 
confl icting results 
 7. Specifi city  If possible, a single putative cause 
produces a specifi c eff ect 
 It is currently unclear to what 
extent the presence of other 
nutrients in foods that are high in 
dietary fi ber (e.g., vitamins, anti-
oxidants, alkali) is responsible for 
the observed health benefi ts 
 8. Biological 
coherence 
 The association is consistent with 
the natural history of the disease 
 An improved cardiovascular risk 
profi le (such as seen with a high-
dietary-fi ber diet) should result in 
lower mortality 
 9. Analogy  There are similar associations in 
other populations or diff erent 
settings 
 Similar, but less strong, associa-
tions are observed in non-CKD as 
compared with CKD populations 
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 Th e relationship between elevated systemic 
blood pressure (BP) and kidney disease, 
either by cause or by consequence, is immu-
 In conclusion, the study of Krishna-
murthy  et al. 1 adds to a growing body of 
evidence that dietary fi ber has important 
health-promoting properties. Dietary fi ber 
may compensate for the detrimental eff ects 
of dietary protein. Dietary fi ber and pro-
tein may thus be referred to as the yin and 
yang of Western nutrition. Rather than 
restricting the dietary protein intake, with 
inherent risks of inducing malnutrition, 
more eff orts should be taken to increase 
dietary fiber intake. Prebiotics may be 
a safe and equally effi  cacious alternative 
to increase the intake of fermentable 
carbohydrates in CKD. Health benefi ts of 
prebiotics in patients with CKD remain to 
be demonstrated by adequately designed 
and powered studies. 
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 Figure 1  |  Pathophysiological pathways linking high dietary fiber intake with decreased 
cardiovascular and infectious morbidity and mortality. SCFAs, short-chain fatty acids. 
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 Prehypertension and chronic 
kidney disease: the ox or the plow ? 
 John P.  Middleton 1 and  Steven D.  Crowley 1 
 Nearly ten years ago, practice recommendations supported use of the 
clinical classification of   ‘ prehypertension ’ for people with systolic blood 
pressure of 120 – 139  mm  Hg or diastolic pressure of 80 – 89  mm  Hg. 
This recommendation was based on observations that these ranges 
of blood pressure were associated with enhanced cardiovascular 
and cerebrovascular risks compared with blood pressure less than 
120 / 80  mm  Hg. Recent observations, including the report by Yano 
and colleagues, also suggest that prehypertension is an important risk 
factor for the development of chronic kidney disease. 
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table. People with BP that far exceeds aver-
age values are at risk of developing chronic 
kidney disease (CKD). The CKD that 
results from hypertension is a leading cause 
of end-stage kidney disease in the United 
States, and the ethnic predilection for 
hypertensive nephrosclerosis contributes to 
an incidence rate of end-stage kidney dis-
ease that is 3.6 times higher in African 
